EMCDDA expert meetings

The EMCDDA regularly organises expert meetings, engaging with leading experts in the drugs field with the aim of developing and improving the scientific tools the agency uses in its work. These expert meetings are listed in the table below. 

Date Meeting Location
22.07.2016 Meeting on the risk assessment of the new psychoactive substance MDMB-CHMICA Lisbon
20.06.2016 Annual EMCDDA expert meeting on the problem drug use (PDU) indicator EMCDDA
08.06.2016 Treatment demand indicator (TDI) experts meeting Lisbon, Portugal
06.06.2016 Annual EMCDDA expert meeting on the Key Indicator ‘Drug Related Infectious Diseases' (DRID) Lisbon, Portugal
19.05.2016 16th annual meeting of the Reitox Early Warning System (EWS) in conjunction with the 5th Law Enforcement Expert Meeting on New Psychoactive Substances Lisbon, Portugal
07.04.2016 Euro-DEN Research Group meeting Lisbon, Portugal
23.11.2015 4th Reitox extended week (2015) Lisbon, Portugal
18.11.2015 Meeting on the risk assessment of the new psychoactive substance α–PVP Lisbon
28.10.2015 Expert meeting on health responses to NPS
08.09.2015 Legal and policy correspondents meeting Lisbon, Portugal
15.06.2015 EMCDDA meeting on the key indicator on Drug-related Infectious Diseases (DRID) Lisbon, Portugal
08.06.2015 Early Warning System annual expert meeting Lisbon, Portugal
27.02.2015 EURO-DEN Steering Committee Meeting Lisbon, Portugal
24.11.2014 3rd EMCDDA Reitox week (2014) Lisbon, Portugal
14.10.2014 Meeting: 'Take home naloxone to reduce fatalities: scaling up a participatory intervention across Europe' Lisbon
14.10.2014 DRD drug-related deaths (DRD) and Drug-related infectious diseases (DRID) key epidemiological indicators annual expert meetings, and satellite event on naloxone, 2014 Lisbon
14.10.2014 Take home naloxone to reduce fatalities: scaling up a participatory intervention across Europe Lisbon, Portugal
23.09.2014 EMCDDA event incorporating the Treatment Demand and High-Risk Drug Use/Problem Drug Use key epidemiological indicators expert meetings 2014 Lisbon
16.09.2014 Meeting on the risk assessment of the new psychoactive substance 4,4’-DMAR and MT-45 Lisbon
25.06.2014 Meeting: 'A comparative analysis of national treatment systems', 2014 Lisbon

Top